Jamshid Maddahi MD FACC, FASNC
Interventional Cardiology
Clinical Professor, Medicine (Cardiology) and Molecular & Medical Pharmacology (Nuclear Medicine) UCLA School of Medicine
Join to View Full Profile
100 UCLA Medical PlzSte 410Los Angeles, CA 90024
Phone+1 310-824-4991
Fax+1 310-824-7082
Dr. Maddahi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1977 - 1981
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1975 - 1977
Tehran University of Medical Sciences School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1977 - 2026
IN State Medical License 1977 - 1978
American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158 Start of enrollment: 2007 Sep 01
- A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress Start of enrollment: 2008 Jun 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 32 citationsFlurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.Jamshid Maddahi, Denis Agostini, Timothy M Bateman, Jeroen J Bax, Rob S B Beanlands
Journal of the American College of Cardiology. 2023-10-17 - 7 citations18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease cate...René R Sevag Packard, John R Votaw, C David Cooke, Kenneth F Van Train, Ernest V Garcia
European Heart Journal. Cardiovascular Imaging. 2022-11-17 - 11 citationsImproved myocardial blood flow estimation with residual activity correction and motion correction inF-flurpiridaz PET myocardial perfusion imaging.Yuka Otaki, Serge D Van Kriekinge, Chih-Chun Wei, Paul Kavanagh, Ananya Singh
European Journal of Nuclear Medicine and Molecular Imaging. 2022-05-01
Press Mentions
Revolutionizing Cardiovascular Imaging with FlurpiridazFebruary 10th, 2025- GE HealthCare Moves PET/CT Scanner Production to United StatesOctober 24th, 2024
- A Closer Look at How FDA's Flurpiridaz Approval Will Impact Nuclear CardiologyOctober 9th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
